T2 Biosystems has announced the appointment of diagnostics industry veteran John Sperzel as president and chief executive officer, succeeding John McDonough, who will continue with his board leadership role, serving as nonexecutive chairman.
Read MoreThe Karius test detected bloodstream infections in 75% of cases as early as 3 days before pediatric leukemia patients became symptomatic.
Read More
With study data and information about participants’ sesame-allergic status, researchers have developed a mathematical model for determining the probability that a child with food allergy is allergic to sesame.
Read More
Rapid molecular diagnostics contribute to improved patient outcomes.
Read More
Users of the Aurora system can combine all of their markers in one sample, and still achieve high resolution for each individual marker.
Read More